Leveraging real-world examples from the first fully virtual clinical trial in the urogynecology space, our presenters discuss the ways in which digital solutions have helped to increase patient recruitment, engagement, and completion rates.
Leveraging real-world examples from the first fully virtual clinical trial in the urogynecology space, our presenters discuss the ways in which digital solutions have helped to increase patient recruitment, engagement, and completion rates.
Leveraging real-world examples from the first fully virtual clinical trial in the urogynecology space, our presenters discuss the ways in which digital solutions have helped to increase patient recruitment, engagement, and completion rates.
Leveraging real-world examples from the first fully virtual clinical trial in the urogynecology space, our presenters discuss the ways in which digital solutions have helped to increase patient recruitment, engagement, and completion rates.
Leveraging real-world examples from the first fully virtual clinical trial in the urogynecology space, our presenters discuss the ways in which digital solutions have helped to increase patient recruitment, engagement, and completion rates.
Leveraging real-world examples from the first fully virtual clinical trial in the urogynecology space, our presenters discuss the ways in which digital solutions have helped to increase patient recruitment, engagement, and completion rates.
Leveraging real-world examples from the first fully virtual clinical trial in the urogynecology space, our presenters discuss the ways in which digital solutions have helped to increase patient recruitment, engagement, and completion rates.
ObvioHealth recently completed the first-ever fully virtual urogynecology study to evaluate a medical digital intravaginal device for female stress urinary incontinence. In this randomized trial, pelvic floor muscle contractions were monitored.
How do increasingly prevalent DCT methods fit into the existing clinical trial ecosystem? In short: There are complexities. Many eClinical platforms still lack key capabilities, which often require complex integrations with third-party solutions.
How do increasingly prevalent DCT methods fit into the existing clinical trial ecosystem? In short: There are complexities. Many eClinical platforms still lack key capabilities, which often require complex integrations with third-party solutions.